Certified Information Security Manager CISM Practice Test 19
Question 180
Three indicators crossed their approved limits, but escalation records and remediation ownership are missing. The team proposes to verify that breached limits trigger timely escalation and accountable remediation. Who should authorize that decision within documented business and security limits?
- The technical control operator because that role implements the approved configuration — using technical implementation responsibility as approval authority for risk indicators and thresholds.
- The service provider because its contract covers the infrastructure — using contractual delivery responsibility as approval authority for risk indicators and thresholds.
- The independent assurance reviewer who will later test the control — using independent review duties as approval authority for risk indicators and thresholds.
- The accountable business or information owner acting within delegated limits and advised by security and affected functions — for the decision to verify that breached limits trigger timely escalation and accountable remediation.
Explanation
Correct Answer
D:For risk indicators and thresholds, the named accountable authority can balance business, security and legal consequences under its delegated mandate. Specialist staff implement or advise; material deviations require escalation. The decision also addresses the risk that incident counts without thresholds do not trigger timely business risk decisions.
Incorrect Answers
A:Access to technical systems does not automatically confer enterprise authority over risk indicators and thresholds. The operator may recommend or execute a properly authorized decision but cannot unilaterally accept the business consequences.
B:Contractual delivery responsibility and technical expertise do not transfer the enterprise’s ultimate accountability for risk indicators and thresholds. The responsible internal authority must approve consequential decisions.
C:Independent assurance should test and challenge the risk indicators and thresholds decision, not ordinarily authorize the activity it will later evaluate. That would blur accountability and separation of duties.
Question 181
Employees use an external AI assistant for confidential material while AI security, procurement and data responsibilities are unassigned. What governance or response action addresses the stated gap?
- Assign AI, model, data, security, legal and procurement responsibilities.
- Approve restricted AI use with human review, controlled architecture and provider safeguards.
- Review pilot results, model changes and supplier exposures before wider use.
- Evaluate prompt disclosure, unreliable outputs, vendor terms and business harm.
Explanation
Correct Answer
A:Assign AI, model, data, security, legal and procurement responsibilities. The scenario's unresolved need is delegated ownership, and this action produces an approved decision and escalation record for emerging ai and model risk. That directly addresses the risk that confidential prompts and unreliable outputs may create exposure not covered by provider retention assurances.
Incorrect Answers
B:Approve restricted AI use with human review, controlled architecture and provider safeguards is pertinent to implementation, but it depends on a still-missing delegated ownership decision or record. Applying it first would leave the current emerging ai and model risk exposure unresolved, even if that later action is worthwhile.
C:Review pilot results, model changes and supplier exposures before wider use is pertinent to control assurance, but it depends on a still-missing delegated ownership decision or record. Applying it first would leave the current emerging ai and model risk exposure unresolved, even if that later action is worthwhile.
D:Evaluate prompt disclosure, unreliable outputs, vendor terms and business harm is pertinent to risk evaluation, but it depends on a still-missing delegated ownership decision or record. Applying it first would leave the current emerging ai and model risk exposure unresolved, even if that later action is worthwhile.
Question 182
Employees use an external AI assistant for confidential material while AI security, procurement and data responsibilities are unassigned. A director recommends: "Evaluate prompt disclosure, unreliable outputs, vendor terms and business harm." What response best addresses the evidence and decision authority in the case?
- Combine work to evaluate prompt disclosure, unreliable outputs, vendor terms and business harm and approve restricted AI use with human review, controlled architecture and provider safeguards in a single funded milestone; document the decision to assign AI, model, data, security, legal and procurement responsibilities for later closure.
- Address the unmet requirement to assign AI, model, data, security, legal and procurement responsibilities, while separately coordinating urgent protective steps within approved authority.
- Authorize a bounded pilot to evaluate prompt disclosure, unreliable outputs, vendor terms and business harm, then use its results to determine whether the team still needs to assign AI, model, data, security, legal and procurement responsibilities.
- Begin with the alternative action to approve restricted AI use with human review, controlled architecture and provider safeguards and reassess whether the team still needs to assign AI, model, data, security, legal and procurement responsibilities after observing outcomes.
Explanation
Correct Answer
B:This preserves the outstanding delegated ownership decision without treating evaluate prompt disclosure, unreliable outputs, vendor terms and business harm as inherently invalid. The immediate requirement is an approved decision and escalation record. Any urgent safety or containment action can continue if it is authorized under a separate response plan.
Incorrect Answers
A:Bundling treatment activities can be efficient, but funding two other actions does not show the named delegated ownership gap is resolved. The present management decision still needs a responsible owner and supporting evidence.
C:The proposal to evaluate prompt disclosure, unreliable outputs, vendor terms and business harm might be a useful pilot, but the case already identifies a missing delegated ownership requirement. A pilot cannot replace an approved decision and escalation record; it should be assessed only within authorized boundaries.
D:Approve restricted AI use with human review, controlled architecture and provider safeguards can be useful in emerging ai and model risk, but it does not eliminate the unmet requirement to assign AI, model, data, security, legal and procurement responsibilities. The proposed order risks assessing the wrong outcome or missing accountable authorization for the case.
Question 183
Employees use an external AI assistant for confidential material while AI security, procurement and data responsibilities are unassigned. Which evidence should an independent reviewer seek to validate the current management decision?
- A signed exposure and control assessment informing the decision to evaluate prompt disclosure, unreliable outputs, vendor terms and business harm.
- Deployment and representative operating tests demonstrating the decision to approve restricted AI use with human review, controlled architecture and provider safeguards was implemented.
- An approved responsibility and delegation record authorizing the decision to assign AI, model, data, security, legal and procurement responsibilities.
- An assurance log of outcomes, exceptions and follow-up after the decision to review pilot results, model changes and supplier exposures before wider use.
Explanation
Correct Answer
C:An approved responsibility and delegation record authorizing the decision to assign AI, model, data, security, legal and procurement responsibilities. It specifically verifies an approved decision and escalation record, the outstanding requirement in this case. This matters because confidential prompts and unreliable outputs may create exposure not covered by provider retention assurances and an assertion of compliance alone cannot show that the risk has been managed.
Incorrect Answers
A:This demonstrates a later risk evaluation objective, but it cannot substitute for the unresolved delegated ownership decision in the case. The evidence is valuable only when that prerequisite is met.
B:This demonstrates a later implementation objective, but it cannot substitute for the unresolved delegated ownership decision in the case. The evidence is valuable only when that prerequisite is met.
D:This demonstrates a later control assurance objective, but it cannot substitute for the unresolved delegated ownership decision in the case. The evidence is valuable only when that prerequisite is met.
Question 184
AI owners are designated, but retention terms, sensitive prompts and output reliability have not been assessed. An updated assessment raises concern that confidential prompts and unreliable outputs may create exposure not covered by provider retention assurances. Which response keeps the management decision current and accountable?
- Report delivery of the existing emerging ai and model risk plan without reopening the previous risk assumptions.
- Continue the approved emerging ai and model risk exception until its original expiry, keeping the existing acceptance decision.
- Let the delivery team revise the emerging ai and model risk response immediately and seek management ratification afterward.
- Have the delegated risk owner reassess emerging ai and model risk and update the treatment decision to evaluate prompt disclosure, unreliable outputs, vendor terms and business harm if new exposure exceeds tolerance.
Explanation
Correct Answer
D:Exposure and residual acceptance depend on current assumptions. A delegated owner must reassess the new evidence because confidential prompts and unreliable outputs may create exposure not covered by provider retention assurances. The evidence needed to evaluate prompt disclosure, unreliable outputs, vendor terms and business harm should be documented and escalated when the risk exceeds approved tolerance.
Incorrect Answers
A:Historical approvals and task counts do not show that the changed risk remains within tolerance. The new condition warrants a refreshed analysis and accountable response, not solely activity reporting.
B:An exception record is not a substitute for assessing the significance of the new evidence to emerging ai and model risk. Earlier acceptance was conditional on facts that may no longer hold.
C:Urgent actions may be allowed within predelegated incident authority, but unilateral changes by implementers do not replace accountable reassessment and escalation when business impact changes.
Question 185
AI owners are designated, but retention terms, sensitive prompts and output reliability have not been assessed. The committee needs evidence about emerging ai and model risk. Which deliverable would address the identified deficiency most directly?
- A management-endorsed assessment documenting the evidence needed to evaluate prompt disclosure, unreliable outputs, vendor terms and business harm for the outstanding impact assessment.
- A signed delegation and escalation record authorizing the organization to assign AI, model, data, security, legal and procurement responsibilities for the outstanding impact assessment.
- A traceable deployment record and operating test confirming action to approve restricted AI use with human review, controlled architecture and provider safeguards for the outstanding impact assessment.
- An assurance review and corrective-action record confirming results from a decision to review pilot results, model changes and supplier exposures before wider use for the outstanding impact assessment.
Explanation
Correct Answer
A:Evaluate prompt disclosure, unreliable outputs, vendor terms and business harm. The scenario's unresolved need is risk evaluation, and this action produces an evidence-backed assessment of consequences for emerging ai and model risk. That directly addresses the risk that confidential prompts and unreliable outputs may create exposure not covered by provider retention assurances.
Incorrect Answers
B:Assign AI, model, data, security, legal and procurement responsibilities is pertinent to delegated ownership, but the scenario already assumes that prerequisite is established. Repeating it does not provide an evidence-backed assessment of consequences now needed for emerging ai and model risk.
C:Approve restricted AI use with human review, controlled architecture and provider safeguards is pertinent to implementation, but it depends on a still-missing risk evaluation decision or record. Applying it first would leave the current emerging ai and model risk exposure unresolved, even if that later action is worthwhile.
D:Review pilot results, model changes and supplier exposures before wider use is pertinent to control assurance, but it depends on a still-missing risk evaluation decision or record. Applying it first would leave the current emerging ai and model risk exposure unresolved, even if that later action is worthwhile.
Question 186
A restricted AI pilot has been authorized, but required human review and provider safeguards are not operating. Which artifact provides the most relevant proof of an effective response at this point?
- A control-performance review recording exceptions and corrections following work to review pilot results, model changes and supplier exposures before wider use.
- An accountable implementation sign-off and test result for the action to approve restricted AI use with human review, controlled architecture and provider safeguards.
- A version-controlled delegation and escalation memo establishing the authority to assign AI, model, data, security, legal and procurement responsibilities.
- A risk treatment justification with service impact evidence supporting the decision to evaluate prompt disclosure, unreliable outputs, vendor terms and business harm.
Explanation
Correct Answer
B:An accountable implementation sign-off and test result for the action to approve restricted AI use with human review, controlled architecture and provider safeguards. It specifically verifies an implemented and tested treatment, the outstanding requirement in this case. This matters because confidential prompts and unreliable outputs may create exposure not covered by provider retention assurances and an assertion of compliance alone cannot show that the risk has been managed.
Incorrect Answers
A:This demonstrates a later control assurance objective, but it cannot substitute for the unresolved implementation decision in the case. The evidence is valuable only when that prerequisite is met.
C:This would document earlier delegated ownership, which the case has already established. It does not demonstrate an implemented and tested treatment required to resolve the current issue.
D:This would document earlier risk evaluation, which the case has already established. It does not demonstrate an implemented and tested treatment required to resolve the current issue.
Question 187
A restricted AI pilot has been authorized, but required human review and provider safeguards are not operating. Which decision addresses the documented deficiency most directly?
- Reconfirm delegated approval to assign AI, model, data, security, legal and procurement responsibilities.
- Revisit assessed exposure to evaluate prompt disclosure, unreliable outputs, vendor terms and business harm.
- Put the approved plan into operation to approve restricted AI use with human review, controlled architecture and provider safeguards.
- Prepare an effectiveness review to review pilot results, model changes and supplier exposures before wider use.
Explanation
Correct Answer
C:Approve restricted AI use with human review, controlled architecture and provider safeguards. The scenario's unresolved need is implementation, and this action produces an implemented and tested treatment for emerging ai and model risk. That directly addresses the risk that confidential prompts and unreliable outputs may create exposure not covered by provider retention assurances.
Incorrect Answers
A:Assign AI, model, data, security, legal and procurement responsibilities is pertinent to delegated ownership, but the scenario already assumes that prerequisite is established. Repeating it does not provide an implemented and tested treatment now needed for emerging ai and model risk.
B:Evaluate prompt disclosure, unreliable outputs, vendor terms and business harm is pertinent to risk evaluation, but the scenario already assumes that prerequisite is established. Repeating it does not provide an implemented and tested treatment now needed for emerging ai and model risk.
D:Review pilot results, model changes and supplier exposures before wider use is pertinent to control assurance, but it depends on a still-missing implementation decision or record. Applying it first would leave the current emerging ai and model risk exposure unresolved, even if that later action is worthwhile.
Question 188
A restricted AI pilot has been authorized, but required human review and provider safeguards are not operating. A director recommends: "Review pilot results, model changes and supplier exposures before wider use." What response best addresses the evidence and decision authority in the case?
- Begin with the alternative action to assign AI, model, data, security, legal and procurement responsibilities and reassess whether the team still needs to approve restricted AI use with human review, controlled architecture and provider safeguards after observing outcomes.
- Combine work to review pilot results, model changes and supplier exposures before wider use and assign AI, model, data, security, legal and procurement responsibilities in a single funded milestone; document the decision to approve restricted AI use with human review, controlled architecture and provider safeguards for later closure.
- Authorize a bounded pilot to review pilot results, model changes and supplier exposures before wider use, then use its results to determine whether the team still needs to approve restricted AI use with human review, controlled architecture and provider safeguards.
- Address the unmet requirement to approve restricted AI use with human review, controlled architecture and provider safeguards, while separately coordinating urgent protective steps within approved authority.
Explanation
Correct Answer
D:This preserves the outstanding implementation decision without treating review pilot results, model changes and supplier exposures before wider use as inherently invalid. The immediate requirement is an implemented and tested treatment. Any urgent safety or containment action can continue if it is authorized under a separate response plan.
Incorrect Answers
A:Assign AI, model, data, security, legal and procurement responsibilities can be useful in emerging ai and model risk, but it does not eliminate the unmet requirement to approve restricted AI use with human review, controlled architecture and provider safeguards. The proposed order risks assessing the wrong outcome or missing accountable authorization for the case.
B:Bundling treatment activities can be efficient, but funding two other actions does not show the named implementation gap is resolved. The present management decision still needs a responsible owner and supporting evidence.
C:The proposal to review pilot results, model changes and supplier exposures before wider use might be a useful pilot, but the case already identifies a missing implementation requirement. A pilot cannot replace an implemented and tested treatment; it should be assessed only within authorized boundaries.
Question 189
The AI pilot expanded rapidly; model changes and supplier retention practices have not been re-evaluated. The team proposes to review pilot results, model changes and supplier exposures before wider use. Who should authorize that decision within documented business and security limits?
- The accountable business or information owner acting within delegated limits and advised by security and affected functions — for the decision to review pilot results, model changes and supplier exposures before wider use.
- The technical control operator because that role implements the approved configuration — using technical implementation responsibility as approval authority for emerging ai and model risk.
- The service provider because its contract covers the infrastructure — using contractual delivery responsibility as approval authority for emerging ai and model risk.
- The independent assurance reviewer who will later test the control — using independent review duties as approval authority for emerging ai and model risk.
Explanation
Correct Answer
A:For emerging ai and model risk, the named accountable authority can balance business, security and legal consequences under its delegated mandate. Specialist staff implement or advise; material deviations require escalation. The decision also addresses the risk that confidential prompts and unreliable outputs may create exposure not covered by provider retention assurances.
Incorrect Answers
B:Access to technical systems does not automatically confer enterprise authority over emerging ai and model risk. The operator may recommend or execute a properly authorized decision but cannot unilaterally accept the business consequences.
C:Contractual delivery responsibility and technical expertise do not transfer the enterprise’s ultimate accountability for emerging ai and model risk. The responsible internal authority must approve consequential decisions.
D:Independent assurance should test and challenge the emerging ai and model risk decision, not ordinarily authorize the activity it will later evaluate. That would blur accountability and separation of duties.
Question 190
The AI pilot expanded rapidly; model changes and supplier retention practices have not been re-evaluated. An updated assessment raises concern that confidential prompts and unreliable outputs may create exposure not covered by provider retention assurances. Which response keeps the management decision current and accountable?
- Let the delivery team revise the emerging ai and model risk response immediately and seek management ratification afterward.
- Have the delegated risk owner reassess emerging ai and model risk and update the treatment decision to review pilot results, model changes and supplier exposures before wider use if new exposure exceeds tolerance.
- Report delivery of the existing emerging ai and model risk plan without reopening the previous risk assumptions.
- Continue the approved emerging ai and model risk exception until its original expiry, keeping the existing acceptance decision.
Explanation
Correct Answer
B:Exposure and residual acceptance depend on current assumptions. A delegated owner must reassess the new evidence because confidential prompts and unreliable outputs may create exposure not covered by provider retention assurances. The evidence needed to review pilot results, model changes and supplier exposures before wider use should be documented and escalated when the risk exceeds approved tolerance.
Incorrect Answers
A:Urgent actions may be allowed within predelegated incident authority, but unilateral changes by implementers do not replace accountable reassessment and escalation when business impact changes.
C:Historical approvals and task counts do not show that the changed risk remains within tolerance. The new condition warrants a refreshed analysis and accountable response, not solely activity reporting.
D:An exception record is not a substitute for assessing the significance of the new evidence to emerging ai and model risk. Earlier acceptance was conditional on facts that may no longer hold.